drugset / Trial / NCT01220622

Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes

NCT01220622

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The trial was designed to test the hypothesis that early treatment with nimodipine has a positive effect on cognition impairment after acute ischemic stroke.

Timeline

Start
2010-10
Primary completion
2012-04
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nimodipine Small molecule 30 mg